BIOJECT RECIEVES REGISTRATION APPROVAL IN ECUADOR
Tigard, OR –October 21, 2015 – Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has received registration approval for its needle-free injection products from the Ministry of Health in Ecuador. Bioject’s distributor in Ecuador, FlashMed Inc. acted as the agent for the application based on documentation provided by Bioject.
"This is the first step to providing Bioject’s needle-free technology to clinicians and patients in Ecuador and we very much appreciate the work of FlashMed in achieving this approval.” said Tony K. Chow President and CEO of Bioject. “We’re looking forward to supporting FlashMed in their efforts and the prospects for new sales in the region.”
Beginning in 2013 Bioject has expanded its distribution network into Asia, Australia, the Philippines, the Middle East, and Africa. So far, registration approvals have been received in nine countries.
